Mounjaro is approved for individuals with type 2 diabetes, while Zepbound is approved for weight loss and obstructive sleep apnea in people with obesity. Pretty much everything else between these two medications is the same
The answer, though, is almost certainly simpler than you think
The treatment process begins with an initial consultation where we assess your health history and determine if peptide therapy aligns with your wellness goals
FDA Approves New Drug Treatment for Chronic Weight Management [ ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al
E.ChaneyM
In addition to these causes, certain systemic conditions, such as fibromyalgia or autoimmune disorders, can manifest as pain in various parts of the body, including the ears and jaw